$5.1 MILLION TO HELP THE JEWISH GENERAL HOSPITAL’S SEGAL CANCER CENTRE FIGHT ALL WOMEN’S CANCERS
THE PHARMAPRIX® WEEKEND TO END WOMEN’S CANCERS™ 2-DAY 60-KM. WALK UNITES 2.250 PARTICIPANTS
Click here to visit the Online Newsroom


Highlights from Today's Opening Ceremonies.



  Facebook
  Digg
  Del.icio.us
  Stumble Upon
  Technorati
  Reddit
  Yahoo Bookmarks
  Google Bookmarks


  Facebook
  Twitter
  YouTube

  Subscribe to the Weekend's RSS Feed
For Immediate Release

Media Contact:
Kim Gradek
Communications Coordinator
C: 514-929-9255

MONTREAL (August 28, 2010)

NEWS FACTS:
  • The Jewish General Hospital announced today that 2,250 participants have raised $5.1 million in the sixth annual Pharmaprix Weekend to End Women’s Cancers.
  • The Montreal-based event is the largest women’s cancers fundraising event in Quebec.
  • During the past five years, previous editions of this event have generated revenue of over $40 million.
  • The seventh annual Pharmaprix Weekend to End Women’s Cancers is already planned for August 27-28, 2011.
  • After an uplifting Opening Ceremony at Jarry Park, participants embarked on a scenic walk though the streets of Montreal. Their day’s journey will end once they reach “Tent City” at Queen of Angels Academy for evening activities, special entertainment and a night of camping under the stars.
  • Walkers will complete the two-day 60-km. walk on Sunday with a memorable closing ceremony that will mark the end of this incredible weekend. Friends and family are invited to greet the walkers and cheer them on as they cross the finish line.
  • One in seven Canadian women will be diagnosed with breast or gynecological cancer in her lifetime. The Pharmaprix Weekend to End Women’s Cancers has broadened its mission beyond breast cancer and is now fighting all women’s cancers.
  • Over the past five years, the funds raised through the Weekend have enabled the Jewish General Hospital to equip two state-of-the art laboratories in the Segal Cancer Centre and the Cell Imaging Facility; fund innovative and in-depth molecular and genetic studies, that have moved the prospect of 'personalized therapy' forward; develop patient-based programs such as for lymphoedema, in the hospital; recruit internationally renowned and highly productive researchers; and invest in exploring new technology, such as robot-assisted surgery for gynecologic cancers.
  • For more information, or to get involved, please call (514) 393-WALK (9255) or visit www.endcancer.ca.
  • The Jewish General Hospital gratefully acknowledges the event sponsors for their commitment to this cause: Pharmaprix, CTV, The Q 92.5, Rythme FM, Montréal en Santé, Royale, Oasis, Fraser Milner Casgrain, Reitmans, Sports Experts, HD Supply Litemor, Sleeman, Queen of Angels Academy.
QUOTES

Myer Bick, President and CEO of the Jewish General Hospital Foundation
  • "As the President of the Jewish General Hospital Foundation, I am extremely proud to be among these Weekend warriors. Their dedication, hard work and ongoing efforts allow us to pursue vital research and improve the care and services that the JGH offers its patients."
Participant Sylvie Breton, ovarian cancer survivor
  • "It is with mixed emotions that I walk in the Pharmaprix Weekend to End Women’s Cancers. I am proud to be a four-year ovarian cancer survivor, but there isn’t a day when my late sister, Rejeanne, isn’t in my heart and in my thoughts. Her life was cut short; she passed away after battling cancer. For Rejeanne, for all those who have been touched by women’s cancers, and for those who were fortunate enough to survive, we walk. Together, we will make a difference to cure one, cure all!"
Dr. Walter Gotlieb, Segal Cancer Centre
  • "We are very excited by the opportunity that the Weekend provides to further refine the treatment and diagnosis of gynecologic cancers. We currently have several avenues of research. One project focuses on targeting the growth-factor pathways in gynecologic cancer. We are also testing several new experimental treatments, some of which are showing much promise, and we continue to enhance the applications and extend the indications of robotic surgery for gynecologic cancers."
About the Segal Cancer Centre
The Segal Cancer Centre is a Quebec leader in implementing a focused and comprehensive approach to fighting cancer through medical treatment, patient care, family support and scientific research. A wide array of interrelated services are grouped in close proximity to one another, including screening and prevention, nutrition and rehabilitation, psychosocial support, symptom management, and public information. This integrated approach is considered by leading international medical experts to be one of the most effective and promising strategies in battling cancer.

About the Jewish General Hospital
Now in its landmark 75th year of providing Care for All, the Jewish General Hospital has been a mainstay of superior medical treatment for many generations of patients from all backgrounds in Montreal, throughout Quebec and beyond. Drawing on its expertise and experience as one of the province’s largest and busiest acute-care hospitals, the JGH is committed to improving the level of care for all Quebecers through close collaboration with the government and its healthcare network. In this anniversary year, the Jewish General Hospital has also redoubled its commitment to ensuring that patients receive care of the highest quality in a clean, safe environment. The JGH has been able to deliver these pioneering and innovative services by strengthening its role as a McGill University teaching hospital, expanding and upgrading its facilities, and pursuing cutting-edge studies at the Lady Davis Institute for Medical Research. For more, please visit jgh.ca.

 

All active news articles